Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jan, Bezouška"'
Autor:
Renata Černá Pařízková, Jiřina Martínková, Eduard Havel, Petr Šafránek, Milan Kaška, David Astapenko, Jan Bezouška, Jaroslav Chládek, Vladimír Černý
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-9 (2021)
Abstract Background Meropenem dosing for septic critically patients is difficult due to pathophysiological changes associated with sepsis as well as supportive symptomatic therapies. A prospective single-center study assessed whether fluid retention
Externí odkaz:
https://doaj.org/article/a76aa8feec604a168cc8ab090189481a
Autor:
Milan, Kaška, Eduard, Havel, Lenka, Javorská, Kateřina, Matoušová, Jiří, Páral, Milan, Chobola, Petr, Šafránek, Jan, Bezouška, Lenka Kujovská, Krčmová
Publikováno v:
Clinical nutrition ESPEN. 45
Enhanced recovery after surgery (ERAS) is currently the modern perioperative method of care for improvement of post-surgery patient condition and for minimising various postoperative complications. A question of some negative impact of early postoper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d2c32246b3e3cba9e84eda4daf2db19
https://pubmed.ncbi.nlm.nih.gov/34620311
https://pubmed.ncbi.nlm.nih.gov/34620311
Autor:
Vera Radochova, Ales Ryska, Zdenek Turek, Slavomir Blazej, Jiri Paral, Jan Bezouška, Boris Jegorov, Milan Kaška
Publikováno v:
Clinical Hemorheology and Microcirculation. 68:61-70
Background The optimal surgical approach to reconnecting bowel ends safely after resection is of great importance. Objectives This project is focused on assessment of the perianastomotic microcirculation quality in the short postoperative period when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d8b56603e107ec807cbe2de2d68cf6
https://doi.org/10.3233/ch-170297
https://doi.org/10.3233/ch-170297
Autor:
Miriam Lánská, Stanislav Filip, Martínková J, J. Malakova, Jan Bezouška, Ondřej Kubeček, Milan Bláha, Jiří Špaček
Publikováno v:
Atherosclerosis. Supplements. 30
Introduction Nanoparticle-based drug delivery systems can overcome the dose-limited toxicity of cytostatics. Pegylated doxorubicin-containing liposomes (PLD) are able to reduce cardiotoxicity. PLD quickly (in 2 days) attains therapeutic concentration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b1a192e7a38831eb7cdff85a28b830
https://pubmed.ncbi.nlm.nih.gov/29096853
https://pubmed.ncbi.nlm.nih.gov/29096853
Autor:
Ondřej Kubeček, Martínková J, Jan Bezouška, Iva Selke Krulichová, Jana Malakova, Stanislav Filip, Milan Bláha, Jiří Špaček
Publikováno v:
Cancer chemotherapy and pharmacology. 77(2)
To examine the removal of pegylated liposomal doxorubicin (PLD) during plasmafiltration (PF) and determine whether the drug could be withheld prior to its organ distribution responsible for mucocutaneous toxicity. Six patients suffering from platinum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c3f20dccc190c7ff6e6c4d4c675f3cf
https://pubmed.ncbi.nlm.nih.gov/26678853
https://pubmed.ncbi.nlm.nih.gov/26678853
Publikováno v:
Anaesthesiology intensive therapy. 48(1)
Background: In critically ill patients, multi-trauma and intensive therapy can influence the pharmacokinetics (PK) and pharmacodynamics (PD) of antibiotics with time-dependent bacterial killing. Consequently, PK/PD targets (%fT >MIC ) — crucial for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8826b8493ef66f7421b7baa749ddf11
https://pubmed.ncbi.nlm.nih.gov/26588478
https://pubmed.ncbi.nlm.nih.gov/26588478